Mindfulness and Biofeedback for Anxiety Disorders
NCT: NCT07628153 · COMPLETED
Brief Summary
This randomized controlled trial compared the effectiveness of a 10-day mindfulness training program using adaptive biofeedback (BFB) versus medication therapy (escitalopram 10 mg/day) versus combined treatment (BFB + medication) in inpatients with anxiety disorders (ICD-10 F40/F41). The primary outcomes were changes in anxiety (Hamilton Anxiety Rating Scale, HARS) and mindfulness (Five Facet Mindfulness Questionnaire, FFMQ) from baseline to post-treatment and at one-month follow-up.
Frequently Asked Questions
What is Mindfulness and Biofeedback for Anxiety Disorders?
Mindfulness and Biofeedback for Anxiety Disorders is a clinical trial registered under NCT07628153. Current status: COMPLETED.
What is the status of NCT07628153?
The current status of NCT07628153 (Mindfulness and Biofeedback for Anxiety Disorders) is: COMPLETED.
When did Mindfulness and Biofeedback for Anxiety Disorders start?
Mindfulness and Biofeedback for Anxiety Disorders started on 2022-07-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.